Latest News

 Filter by Provider

America is no longer in a normal business cycle, but instead entering a Fourth Turning–style crisis driven by debt saturation, collapsing affordability, and a loss of trust in key institutions.

We discuss a year as volatile as 2025 has been so far.

One trader cited fiscal strength and an aggressive buyback plan.

The SCHD ETF has underperformed the market this year.

Analyst Gil Blum initiated coverage of Solid Biosciences with a Buy rating and $16 price target, citing emerging gene therapies.

Anthropic recently signed a multibillion-dollar deal with Nvidia and Microsoft.

Netflix is reportedly the primary bidder for the purchase of Warner Bros Discovery's assets, which raised investor concerns.

The CEO of one tech giant recently admitted that no company will be immune if the artificial intelligence (AI) bubble bursts.

One fund’s decision to walk away from Eastman Chemical may illuminate what’s really driving the stock’s prolonged slide.

Using quantitative data and screening tools to create quantitative rules-driven portfolios that can be used for portfolio management or broadened to provide selection sets for active management.

The U.S. DOE just gave BWX stock a big boost.

The stock has climbed in the double-digits in recent years.

One detail in the latest earnings suggests why some deep-value investors may see more upside than the stock chart implies.

Silver has taken us on a wild ride, nearly doubling in price this year. However, some analysts worry that silver is taking us down a path of disappointment.

The digital advertising sector is seeing strong growth fueled by AI.

The company didn't report any positive news, but that doesn't mean investors don't have a reason to click the buy button.

This fund just made Axalta one of its largest bets—here’s why its latest results may explain the move.

Filosa said that the company is on track on its full year guidance through the end of November.

XRP ETFs are nearing $1B in assets, with Ripple CEO Garlinghouse stating that the crypto market is still in its early stages.

UiPath Inc (NYSE: PATH) stocks surged after reporting strong Q3 results, with Canaccord Genuity analyst raising price target to $19 and Needham maintaining Hold rating.

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

A wide range of dividend stocks are approaching their payout dates this December, offering yields from 0.66% to 8.05% across several sectors.

XRP (CRYPTO: XRP) dropped 4% on Thursday, but technical analysis shows Cardano

Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.

Broadcom has all the ingredients to be the market's biggest chip winner next year.

After a rapid November rally, silver bulls are struggling to break through the psychological barrier of 6000.

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from the wider excitement in obesity treatment area and the recent positive momentum after major clinical trial developments.

Space stocks blasted back into the spotlight this week as retail investors turned up the heat in the sector.

The Dow Jones treaded water on Thursday as markets await next week’s Fed rate call.

ArrowMark’s sharp reduction in its Alight stake comes at a moment when the market is questioning whether the company can turn its consulting-heavy work into steadier recurring revenue, and that tension may say more about sentiment than about the strength of the platform itself.

Today’s financial system allows many promises of future goods and services. However, the quantity of actual physical goods and services that can be produced appears likely to be shrinking in future years because of resource depletion.

Alice Liu, Head of Research at CoinMarketCap, on Tuesday said that crypto has entered a phase of high fear, high volatility, and cautions that Bitcoin's (CRYPTO:

Gold holds above $4,200 as markets maintain 85% odds of a Fed rate cut next week.

New York, NY – December 4, 2025 – Wall Street is currently navigating a period of palpable tension and cautious optimism, with market volatility predominantly fueled by the fervent anticipation of imminent Federal Reserve interest rate cuts. As the year draws to a close, investors find themselves in a "holding breath" stance,

AUD/USD finally reclaimed the 0.6600 barrier and beyond for the first time since early October.

As of early December 2025, the U.S. stock market finds itself in a precarious yet optimistic position, with both the Dow Jones Industrial Average and the S&P 500 index hovering tantalizingly close to their all-time record highs. This remarkable resilience in equity valuations comes amidst a period of

Chemical companies have been having a rough year.

March NY world sugar #11 (SBH26 ) on Thursday closed down -0.05 (-0.33%), and March London ICE white sugar #5 (SWH26 ) closed down -1.00 (-0.23%). Sugar prices finished lower on Thursday, consolidating this week's losses. On Monday, sugar prices fel...

December 4, 2025 – Gold prices are holding remarkably firm, hovering near multi-month highs, as robust expectations for Federal Reserve interest rate cuts continue to dominate market sentiment. This resilience in the precious metal persists even amidst a backdrop of mixed US labor data, which, rather than dampening dovish bets, appears